Boston Common Asset Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.12M | Sell |
15,738
-4,567
| -22% | -$1.78M | 0.17% | 166 |
|
|
2025
Q1 | $8.83M | Buy |
20,305
+3,579
| +21% | +$1.56M | 0.27% | 131 |
|
|
2024
Q4 | $6.17M | Buy |
16,726
+4,637
| +38% | +$1.71M | 0.18% | 158 |
|
|
2024
Q3 | $6.29M | Buy |
+12,089
| New | +$6.29M | 0.16% | 166 |
|
|
2023
Q1 | – | Sell |
-856
| Closed | -$439K | – | 317 |
|
|
2022
Q4 | $439K | Buy |
856
+17
| +2% | +$8.72K | 0.02% | 209 |
|
|
2022
Q3 | $381K | Buy |
839
+344
| +69% | +$156K | 0.02% | 218 |
|
|
2022
Q2 | $239K | Sell |
495
-266
| -35% | -$128K | 0.01% | 250 |
|
|
2022
Q1 | $374K | Sell |
761
-92
| -11% | -$45.2K | 0.02% | 228 |
|
|
2021
Q4 | $395K | Buy |
853
+42
| +5% | +$19.4K | 0.02% | 222 |
|
|
2021
Q3 | $302K | Buy |
811
+2
| +0.2% | +$745 | 0.01% | 228 |
|
|
2021
Q2 | $309K | Buy |
809
+55
| +7% | +$21K | 0.01% | 230 |
|
|
2021
Q1 | $271K | Sell |
754
-3
| -0.4% | -$1.08K | 0.02% | 232 |
|
|
2020
Q4 | $243K | Buy |
+757
| New | +$243K | 0.02% | 226 |
|